Esmolol 10 mg/ml Solution for injection
Esmolol is indicated for supraventricular tachycardia (except for preexcitation syndromes), and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable. Esmolol is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia where, in the physician's judgment the rapid heart rate requires specific intervention. Esmolol is not indicated for use in children aged up to 18 years (see section 4.2). Esmolol is not intended for use in chronic settings.